Last week the FDA updated its Compliance monitoring program Chapter 48 – Bioresearch Monitoring to include 'in vitro' GLP tests (see p25 in the linked document). Whether this is related to the Agency's plans for implementing Novel Alternative Methodologies to replace animal safety testing in coming years remains to be seen.
#FDA #NAM #GLP #invitro
https://www.fda.gov/media/75891/download
------------------------------
Mark Arnold Ph.D., FAAPS
Westampton, NJ
[email protected]Bioanalytical Solution Integration
LinkedIn:
https://www.linkedin.com/in/markearnoldphd/Website & Blog: Bioanalysis & Biomarkers <bioanalysisandbiomarkers.blogspot.com>
------------------------------
</bioanalysisandbiomarkers.blogspot.com>